References
- Brenzan MA, Nakamura CV, Prado-Dias Filho B, Ueda-Nakamura T, Young MCM, Garcia-Cortez DA. 2007. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res. 101(3):715–722.
- Cardoso BM, De Mello TF, Lera DS, Brenzan MA, Cortez DA, Donatti L, Silveira TG, Lonardoni MV. 2016. Antileishmanial activity of a Calophyllum brasiliense leaf extract. Planta Med. 83(01/02):57–62.
- Cechinel-Filho V, Meyre-Silva C, Niero R. 2009. Chemical and pharmacological aspects of the genus Calophyllum. C&B. 6(3):313–327.
- Da Silva KL, dos Santos AR, Mattos PE, Yunes RA, Delle-Monache F, Cechinel-Filho V. 2001. Chemical composition and analgesic activity of Calophyllum brasiliense leaves. Therapie. 56(4):431–434.
- Huerta-Reyes M, Basualdo MC, Abe F, Jimenez-Estrada M, Soler C, Reyes-Chilpa R. 2004. HIV-1 Inhibitory compounds from Calophyllum brasiliense leaves. Biol Pharm Bull. 27(9):1471–1475.
- Ito C, Fujiwara K, Kajita M, Ju-Ichi M, Takemura Y, Suzuki Y, Tanaka K, Omura M, Furukawa H. 1991. New coumarins from Citrus plants. Chem Pharm Bull. 39(10):2509–2513.
- Ito C, Itoigawa M, Mishina Y, Filho VC, Mukainaka T, Tokuda H, Nishino H, Furukawa H. 2002. Chemical constituents of Calophyllum brasiliense: structure elucidation of seven new xanthones and their cancer chemopreventive activity. J Nat Prod. 65(3):267–272.
- McKee TC, Fuller RW, Covington CD, Cardellina JH, Gulakowski RJ, Krepps BL, McMahon JB, Boyd MR. 1996. New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii. J Nat Prod. 59(8):754–758.
- Oliveira EA, Brito IA, Lima ML, Romanelli M, Moreira-Filho JT, Neves BJ, Andrade CH, Sartorelli P, Tempone AG, Costa-Silva TA, et al. 2019. Antitrypanosomal activity of acetogenins isolated from the seeds of Porcelia macrocarpa is associated with alterations in both plasma membrane electric potential and mitochondrial membrane potential. J Nat Prod. 82(5):1177–1182.
- Pecoul B, Batista C, Stobbaerts E, Ribeiro I, Vilasanjuan R, Gascon J, Pinazo MJ, Moriana S, Gold S, Pereiro A, et al. 2016. The BENEFIT Trial: where do we go from here? PLoS Negl Trop Dis. 10(2):e0004343.
- Peeling RW, Boeras DI, Nkengasong J. 2017. Re-imagining the future of diagnosis of Neglected Tropical Diseases. Comput Struct Biotechnol J. 15:271–274.
- Rea A, Tempone AG, Pinto EG, Mesquita JT, Rodrigues E, Silva LG, Sartorelli P, Lago J. 2013. Soulamarin isolated from Calophyllum brasiliense (Clusiaceae) induces plasma membrane permeabilization of Trypanosoma cruzi and mytochondrial dysfunction. PLoS Negl Trop Dis. 7(12):e2556.
- Reyes-Chilpa R, Estrada-Muñiz E, Apan TR, Amekraz B, Aumelas A, Jankowski CK, Vázquez-Torres M. 2004. Cytotoxic effects of mammea type coumarins from Calophyllum brasiliense. Life Sci. 75(13):1635–1647.
- Sales-Junior PA, Molina I, Fonseca-Murta SM, Sánchez-Montalvá A, Salvador F, Corrêa-Oliveira R, Carneiro CM. 2017. Experimental and clinical treatment of Chagas disease: a review. Am J Trop Med Hyg. 97(5):1289–1303.
- Sartori NT, Canepelle D, de Sousa PT, Martins DTO. 1999. Gastroprotective effect from Calophyllum brasiliense Camb. bark on experimental gastric lesions in rats and mice. J Ethnopharmacol. 67(2):149–156.